Market Place
Sourcing Support
Rice Biotech Launch Pad and RBL LLC celebrate lab opening
26 Mar 2025 //
PR NEWSWIRE
US FDA greenlights GSK`s drug for UTIs in women and girls
26 Mar 2025 //
PRESS RELEASE
GSK studying if best-selling shingles vaccine lowers dementia risk
25 Mar 2025 //
REUTERS
EMA to review GSK`s asthma drug Nucala to treat COPD
25 Mar 2025 //
REUTERS
GSK posts data on HIV assets vying for roles in 6-month combo
13 Mar 2025 //
PRESS RELEASE
ViiV Healthcare: Zero HIV cases with Apretude in new study
12 Mar 2025 //
BUSINESSWIRE
GSK Appoints Carson Dalton As EVP - Communications, Govt Affairs
04 Mar 2025 //
INDPHARMAPOST
Zymeworks Achieves $14M Milestone from GSK Collaboration
26 Feb 2025 //
GLOBENEWSWIRE
GSK Pharma hits 3-month high in weak market; surges 31% in 7 days
24 Feb 2025 //
BUSINESS STD
Canada purchases 500,000 doses of GSK`s vaccine for bird flu
20 Feb 2025 //
REUTERS
US FDA approves GSK`s combo meningococcal vaccine
18 Feb 2025 //
REUTERS
Hedge fund Citadel takes short position in GSK, FT reports
14 Feb 2025 //
REUTERS
India`s GSK Pharma Profit Rises On Respiratory Drug Demand
14 Feb 2025 //
REUTERS
GSK plots move of vaccine R&D from Maryland to Massachusetts
12 Feb 2025 //
FIERCE BIOTECH
GSK questions Gilead`s potential dominance of the PrEP market
07 Feb 2025 //
FIERCE PHARMA
Energize Supports Global Healthcare Firms with Multi-buyer PPA
06 Feb 2025 //
BUSINESSWIRE
GSK drops 1 potential `cure` for hep B, focuses on bepirovirsen
06 Feb 2025 //
FIERCE BIOTECH
GSK launches $2.5 billion buyback, lifts sales target
06 Feb 2025 //
PRESS RELEASE
GSK beats Q4 earnings estimates, lifts 2031 sales target
05 Feb 2025 //
REUTERS
12.7M Invested In NTDs, Malaria Diagnostics, Drug Development
29 Jan 2025 //
PR NEWSWIRE
Depemokimab Accepted For EMA Review For Asthma & CRSwNP
28 Jan 2025 //
PHARMAWEB
GSK’s Shingrix prefilled syringe presentation accept by EMA
27 Jan 2025 //
PHARMAWEB
GSK and Oxford University ink cancer vaccine research pact
26 Jan 2025 //
FIERCE BIOTECH
GSK to buy US biotech firm IDRx for up to $1.15 billion
14 Jan 2025 //
PRESS RELEASE
Ouro Launches to Advance Treatments for Immune-Mediated Diseases
10 Jan 2025 //
PR NEWSWIRE
GSK & Pfizer`s RSV vaccines to carry warnings of neurological risk
08 Jan 2025 //
FDA
GSK’s Nucala bags another China approval
06 Jan 2025 //
PRESS RELEASE
What can AZ`s China probes teach other biopharma companies?
28 Dec 2024 //
FIERCE PHARMA
GSK`s cancer drug combo meets main goal in ovarian cancer trial
23 Dec 2024 //
REUTERS
Relation Announces Collab with GSK on Fibrosis & Osteoarthritis
10 Dec 2024 //
GLOBENEWSWIRE
Relation Partners with GSK for Fibrotic Diseases & Osteoarthritis
10 Dec 2024 //
GLOBENEWSWIRE
GSK pays AI biotech $45M upfront to identify fibrotic targets
10 Dec 2024 //
FIERCE BIOTECH
GSK pair with Relation to develop fibrosis, arthritis therapies
10 Dec 2024 //
GLOBENEWSWIRE
GSK Gets Positive Results in Blood-Cancer Drug Trial
10 Dec 2024 //
REUTERS
Belantamab Mafodotin Shows 42% Survival Benefit in Multiple Myeloma
09 Dec 2024 //
BUSINESSWIRE
Employees` LinkedIn likes land AstraZeneca and GSK in hot water
06 Dec 2024 //
FIERCE PHARMA
GSK taps a startup for shot at Alzheimer’s drug
06 Dec 2024 //
BIOPHARMADIVE
GSK cuts Shingrix deliveries in revised Zhifei China pact
06 Dec 2024 //
FIERCE PHARMA
Muna Partners with GSK to Accelerate Alzheimer’s Treatments
05 Dec 2024 //
PR NEWSWIRE
GSK pays Muna $35M cash to chase new Alzheimer`s drug targets
05 Dec 2024 //
FIERCE BIOTECH
GSK Turns Back to China in Another Potential $1B+ ADC Deal
05 Dec 2024 //
PRESS RELEASE
GSK axes hepatitis B vaccine trial after missing efficacy goal
04 Dec 2024 //
FIERCE BIOTECH
GSK offers Rgenta up to $500M biobucks per target in RNA deal
04 Dec 2024 //
FIERCE BIOTECH
GSK raises awareness of risks of AMR at London train station
02 Dec 2024 //
FIERCE PHARMA
Europe approves GSK’s fully liquid Menveo meningococcal vaccine
29 Nov 2024 //
PHARMABIZ
Science 37 Doubles US Enrollment for GSK Phase 3 Rare Disease Trial
21 Nov 2024 //
GLOBENEWSWIRE
GSK’s itch prospect hits mark in phase 3 liver disease trial
20 Nov 2024 //
FIERCE BIOTECH
GSK Drug Meets Main Goal in Late-Stage Study for Itch Treatment
19 Nov 2024 //
REUTERS
GSK`s ADC Blenrep delivers survival win against J&J`s Darzalex
14 Nov 2024 //
FIERCE PHARMA
GSK takes aim at challenges facing gynecological cancer patients
12 Nov 2024 //
FIERCE PHARMA
GSK Signs Parkinson’s Deal with Flagship’s Vesalius for $570M
12 Nov 2024 //
FIERCE BIOTECH
GSK breaks up with BIO for 2025
09 Nov 2024 //
FIERCE PHARMA
FDA proposes ending use of decongestant present in cold medicines
08 Nov 2024 //
REUTERS
ViiV Health Expand Data on Long-Acting HIV Therapies at HIV Glasgow
07 Nov 2024 //
BUSINESSWIRE
GSK to acquire Chimagen’s CMG1A46 for autoimmune disease
31 Oct 2024 //
PRESS RELEASE
GSK Q2 FY25 Revenue Crosses Rs. 1,000 Cr
30 Oct 2024 //
INDPHARMAPOST
GSK`s RSV vaccine sales plummet in wake of guidance changes
30 Oct 2024 //
FIERCE PHARMA
GlaxoSmithKline India Reports Higher Q2 Profit on Strong Demand
29 Oct 2024 //
REUTERS
GSK embarks on PA manufacturing expansion worth up to $800M
25 Oct 2024 //
FIERCE PHARMA
GSK`s Arexvy shows promise in younger adults
25 Oct 2024 //
FIERCE PHARMA
